Report Detail

Pharma & Healthcare Global Alvimopan Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4619223
  • |
  • 26 September, 2024
  • |
  • Global
  • |
  • 73 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
According to our (Global Info Research) latest study, the global Alvimopan market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report is a detailed and comprehensive analysis for global Alvimopan market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Alvimopan market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/g), 2019-2030
Global Alvimopan market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/g), 2019-2030
Global Alvimopan market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/g), 2019-2030
Global Alvimopan market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (US$/g), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alvimopan
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alvimopan market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Teva Pharmaceutical Industries Ltd, MSN Life Sciences Private Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Alvimopan market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pharmaceutical Grade
Others
Market segment by Application
Pharmaceutical
Other
Major players covered
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alvimopan product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alvimopan, with price, sales quantity, revenue, and global market share of Alvimopan from 2019 to 2024.
Chapter 3, the Alvimopan competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alvimopan breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Alvimopan market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alvimopan.
Chapter 14 and 15, to describe Alvimopan sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Alvimopan Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Pharmaceutical Grade
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Alvimopan Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical
    • 1.4.3 Other
  • 1.5 Global Alvimopan Market Size & Forecast
    • 1.5.1 Global Alvimopan Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Alvimopan Sales Quantity (2019-2030)
    • 1.5.3 Global Alvimopan Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Alvimopan Product and Services
    • 2.1.4 Merck Alvimopan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Teva Pharmaceutical Industries Ltd
    • 2.2.1 Teva Pharmaceutical Industries Ltd Details
    • 2.2.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Product and Services
    • 2.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.3 MSN Life Sciences Private Ltd
    • 2.3.1 MSN Life Sciences Private Ltd Details
    • 2.3.2 MSN Life Sciences Private Ltd Major Business
    • 2.3.3 MSN Life Sciences Private Ltd Alvimopan Product and Services
    • 2.3.4 MSN Life Sciences Private Ltd Alvimopan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 MSN Life Sciences Private Ltd Recent Developments/Updates

3 Competitive Environment: Alvimopan by Manufacturer

  • 3.1 Global Alvimopan Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Alvimopan Revenue by Manufacturer (2019-2024)
  • 3.3 Global Alvimopan Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Alvimopan by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Alvimopan Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Alvimopan Manufacturer Market Share in 2023
  • 3.5 Alvimopan Market: Overall Company Footprint Analysis
    • 3.5.1 Alvimopan Market: Region Footprint
    • 3.5.2 Alvimopan Market: Company Product Type Footprint
    • 3.5.3 Alvimopan Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Alvimopan Market Size by Region
    • 4.1.1 Global Alvimopan Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Alvimopan Consumption Value by Region (2019-2030)
    • 4.1.3 Global Alvimopan Average Price by Region (2019-2030)
  • 4.2 North America Alvimopan Consumption Value (2019-2030)
  • 4.3 Europe Alvimopan Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Alvimopan Consumption Value (2019-2030)
  • 4.5 South America Alvimopan Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Alvimopan Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Alvimopan Sales Quantity by Type (2019-2030)
  • 5.2 Global Alvimopan Consumption Value by Type (2019-2030)
  • 5.3 Global Alvimopan Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Alvimopan Sales Quantity by Application (2019-2030)
  • 6.2 Global Alvimopan Consumption Value by Application (2019-2030)
  • 6.3 Global Alvimopan Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Alvimopan Sales Quantity by Type (2019-2030)
  • 7.2 North America Alvimopan Sales Quantity by Application (2019-2030)
  • 7.3 North America Alvimopan Market Size by Country
    • 7.3.1 North America Alvimopan Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Alvimopan Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Alvimopan Sales Quantity by Type (2019-2030)
  • 8.2 Europe Alvimopan Sales Quantity by Application (2019-2030)
  • 8.3 Europe Alvimopan Market Size by Country
    • 8.3.1 Europe Alvimopan Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Alvimopan Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Alvimopan Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Alvimopan Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Alvimopan Market Size by Region
    • 9.3.1 Asia-Pacific Alvimopan Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Alvimopan Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Alvimopan Sales Quantity by Type (2019-2030)
  • 10.2 South America Alvimopan Sales Quantity by Application (2019-2030)
  • 10.3 South America Alvimopan Market Size by Country
    • 10.3.1 South America Alvimopan Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Alvimopan Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Alvimopan Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Alvimopan Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Alvimopan Market Size by Country
    • 11.3.1 Middle East & Africa Alvimopan Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Alvimopan Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Alvimopan Market Drivers
  • 12.2 Alvimopan Market Restraints
  • 12.3 Alvimopan Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Alvimopan and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Alvimopan
  • 13.3 Alvimopan Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Alvimopan Typical Distributors
  • 14.3 Alvimopan Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Alvimopan. Industry analysis & Market Report on Alvimopan is a syndicated market report, published as Global Alvimopan Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Alvimopan market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,599.56
    3,899.34
    5,199.12
    3,118.08
    4,677.12
    6,236.16
    496,944.00
    745,416.00
    993,888.00
    291,310.80
    436,966.20
    582,621.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report